Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
While Semaglutide targets the GLP-1 receptor, Tirzepatide is a dual-agonist that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
1 This trial demonstrated clinically meaningful reductions in body weight after 68 weeks of treatment
This may include: In rare situations, side effects may include: Discover the ultimate in hydration and wellness with our VIP Intro Offer
This process of protection is typically referred to as the neutralisation of free radicals (more on that later!)
Secondary side effects are also associated with taking GLP-1 drugs
In one case report, Ozempic worsened nausea and vomiting during early pregnancy
